Adult glioblastoma patients with epilepsy syndrome showed a decrease in KCC2 staining in tumor tissue [19] and a reduction in [K+]i and [Cl−]i levels in TMZ-treated glioma cells [24,25]. Here, SLC12A5 is linked to epilepsy syndrome.